DGX

195.05

0.80% -1.58

Dopo l'orario di chiusura: 195.05

Quest Diagnostics Inc (DGX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$196.63

Aprire:

$198.59

Volume 24 ore:

900.03K

Relative Volume:

0.91

Capitalizzazione di mercato:

$21.59B

Reddito:

$11.28B

Utile/perdita netta:

$1.07B

Rapporto P/E:

21.52

EPS:

9.0657

Flusso di cassa netto:

$1.33B

1 W Prestazione:

-4.87%

1M Prestazione:

-0.24%

6M Prestazione:

+9.41%

1 anno Prestazione:

+10.40%

Intervallo 1D:

$194.27

$198.78

Intervallo di 1 settimana:

$194.27

$207.00

Portata 52W:

$164.65

$213.50

Quest Diagnostics Inc Stock (DGX) Company Profile

Nome

Quest Diagnostics Inc

Settore

Healthcare (1107)

Industria

Diagnostics & Research (51)

Telefono

(973) 520-2700

Indirizzo

500 PLAZA DRIVE, SECAUCUS

Dipendente

57,000

Cinguettio

@QuestDX

Prossima data di guadagno

2026-04-21

Ultimi documenti SEC

DGX's Discussions on Twitter

Compare DGX vs TMO, DHR, IDXX, A, WAT

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
DGX Quest Diagnostics Inc	195.05	21.77B	11.28B	1.07B	1.33B	9.0657
TMO Thermo Fisher Scientific Inc	470.22	173.93B	45.20B	6.88B	6.75B	18.19
DHR Danaher Corp	178.98	127.84B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	568.30	45.67B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	114.87	32.67B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	300.73	29.43B	3.17B	642.63M	516.49M	10.77

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-30	Aggiornamento	Barclays	Equal Weight → Overweight
2025-08-25	Downgrade	Robert W. Baird	Outperform → Neutral
2025-04-02	Iniziato	Redburn Atlantic	Buy
2025-03-04	Downgrade	Citigroup	Buy → Neutral
2025-01-06	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-12-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-12-10	Ripresa	Jefferies	Buy
2024-10-23	Aggiornamento	Robert W. Baird	Neutral → Outperform
2024-08-28	Ripresa	Evercore ISI	In-line
2024-07-10	Aggiornamento	Citigroup	Neutral → Buy
2024-02-26	Iniziato	Leerink Partners	Market Perform
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2024-01-03	Iniziato	Barclays	Equal Weight
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-06-29	Iniziato	Piper Sandler	Neutral
2023-05-02	Downgrade	BofA Securities	Buy → Neutral
2023-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-01-23	Iniziato	Evercore ISI	In-line
2022-11-17	Downgrade	Citigroup	Neutral → Sell
2022-08-22	Ripresa	Morgan Stanley	Equal-Weight
2022-04-04	Downgrade	Citigroup	Buy → Neutral
2022-02-23	Downgrade	UBS	Buy → Neutral
2022-02-02	Downgrade	Jefferies	Buy → Hold
2022-01-28	Downgrade	Deutsche Bank	Buy → Hold
2021-05-04	Aggiornamento	UBS	Neutral → Buy
2021-03-12	Downgrade	Robert W. Baird	Outperform → Neutral
2020-10-21	Aggiornamento	Argus	Hold → Buy
2020-07-29	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2020-07-14	Aggiornamento	BofA Securities	Neutral → Buy
2020-06-09	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2020-06-02	Aggiornamento	Deutsche Bank	Hold → Buy
2020-04-28	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-04-27	Aggiornamento	Citigroup	Neutral → Buy
2020-04-27	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2020-03-27	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-01-08	Iniziato	Wells Fargo	Underweight
2020-01-07	Downgrade	Barclays	Overweight → Equal Weight
2019-12-19	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-07-15	Downgrade	Goldman	Neutral → Sell
2019-04-02	Aggiornamento	Jefferies	Hold → Buy
2019-03-18	Ripresa	Credit Suisse	Neutral
2019-01-31	Downgrade	Argus	Buy → Hold
2019-01-17	Iniziato	UBS	Neutral
2019-01-03	Downgrade	BofA/Merrill	Neutral → Underperform
2018-12-03	Downgrade	BofA/Merrill	Buy → Neutral
2018-11-30	Downgrade	Goldman	Buy → Neutral

Mostra tutto

Quest Diagnostics Inc Borsa (DGX) Ultime notizie

05:41 AM

Quest Diagnostics (DGX) sells $500M 5.00% senior notes due 2036 at 98.751% - Stock Titan

05:41 AM

Apr 27, 2026

Smart Money is Buying Quest Diagnostics Inc. (DGX) - The Acquirer's Multiple

Apr 27, 2026

Quest Diagnostics Incorporated (DGX) stock price, news, quote and history - Yahoo Finance Australia

Apr 27, 2026

Quest Diagnostics prices $500 million senior notes offering By Investing.com - Investing.com Canada

Apr 27, 2026

Quest Diagnostics prices $500M debt deal ahead of June note maturity - Stock Titan

Apr 27, 2026

Quest Diagnostics Inc files for senior notes, size not disclosed - marketscreener.com

Apr 27, 2026

Quest Diagnostics (DGX) launches senior note offering; may repay $500M 2026 notes - Stock Titan

Apr 27, 2026

Apr 24, 2026

[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan

Apr 24, 2026

Quest Diagnostics (DGX) SVP reports 49-share dividend reinvestment - Stock Titan

Apr 24, 2026

Quest Diagnostics (NYSE: DGX) director acquires shares through dividend reinvestment - Stock Titan

Apr 24, 2026

Dividend plan boosts Quest Diagnostics (NYSE: DGX) director stake - Stock Titan

Apr 24, 2026

Quest Diagnostics (DGX) director boosts holdings with small dividend reinvestment - Stock Titan

Apr 24, 2026

Quest Diagnostics (NYSE: DGX) SVP reports small 39-share acquisition - Stock Titan

Apr 24, 2026

Quest Diagnostics (NYSE: DGX) SVP adds 37 shares through dividend reinvestment - Stock Titan

Apr 24, 2026

Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 24, 2026

Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely (NYSE:DGX) - Seeking Alpha

Apr 24, 2026

Copeland Capital Management LLC Cuts Stake in Quest Diagnostics Incorporated $DGX - MarketBeat

Apr 24, 2026

Quest Diagnostics Incorporated $DGX Stock Holdings Decreased by Cwm LLC - MarketBeat

Apr 24, 2026

Apr 23, 2026

These Companies Are Raising Guidance This Earnings Season - TradingView

Apr 23, 2026

Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 23, 2026

Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Merck & Company (MRK) - The Globe and Mail

Apr 23, 2026

Zurcher Kantonalbank Zurich Cantonalbank Has $14.02 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat

Apr 23, 2026

Apr 22, 2026

Quest Diagnostics (NYSE: DGX) boosts Q1 2026 earnings on 11% volume growth - Stock Titan

Apr 22, 2026

Quest Diagnostics deal helps push Secaucus office tower past 75% occupancy - Yahoo Finance

Apr 22, 2026

Quest Diagnostics Stock Gains 5% After Q1 Earnings Exceed Analyst Expectations - TIKR.com

Apr 22, 2026

Quest Diagnostics (NYSE:DGX) Price Target Raised to $229.00 - MarketBeat

Apr 22, 2026

Quest Diagnostics (NYSE:DGX) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat

Apr 22, 2026

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings - Benzinga

Apr 22, 2026

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock - Yahoo Finance

Apr 22, 2026

Truist Financial Forecasts Strong Price Appreciation for Quest Diagnostics (NYSE:DGX) Stock - MarketBeat

Apr 22, 2026

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2026 Earnings Call Transcript - Insider Monkey

Apr 22, 2026

Evercore ISI Adjusts Price Target on Quest Diagnostics to $225 From $210, Maintains In Line Rating - marketscreener.com

Apr 22, 2026

Jefferies Adjusts Price Target on Quest Diagnostics to $225 From $220, Maintains Buy Rating - marketscreener.com

Apr 22, 2026

Barclays Adjusts Price Target on Quest Diagnostics to $230 From $225, Maintains Overweight Rating - marketscreener.com

Apr 22, 2026

Baird Adjusts Price Target on Quest Diagnostics to $229 From $224, Maintains Neutral Rating - marketscreener.com

Apr 22, 2026